Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPH Group (T) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Profit before tax | 11.77 | 7.31 | 5.83 | -1.88 | -18.23 |
| Net cashflow-operating activity | 4.95 | 8.03 | -13.61 | -34.27 | -1.10 |
| Net cash used in investing activity | -7.49 | -5.44 | -5.35 | 32.77 | 3.53 |
| Netcash used in fin. activity | 10.18 | -4.22 | 12.28 | 7.27 | -2.44 |
| Net inc/dec in cash and equivlnt | 7.64 | -1.63 | -6.68 | 5.78 | - |
| Cash and equivalnt begin of year | 0.17 | 1.80 | 8.48 | 2.70 | 2.70 |
| Cash and equivalnt end of year | 7.81 | 0.17 | 1.80 | 8.48 | 2.70 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis